SAREPTA THERAPEUTICS, INC. Investments
SAREPTA THERAPEUTICS, INC. (SRPT) had Investments of $362.70 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets
us-gaap:Investments · last filed 2026-08-05
- 2026-06-30: Investments $362.70M.
- 2026-03-31: Investments $270.70M.
- 2025-12-31: Investments $139.40M.
- 2025-09-30: Investments $239.00M.
| Period end | Investments |
|---|---|
| 2026-06-30 | $362.70M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $270.70M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $139.40M 10-K · filed 2026-03-02 |
| 2025-09-30 | $239.00M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $324.10M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $391.00M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $384.90M 10-K · filed 2025-02-28 |
| 2024-09-30 | $1.18B 10-Q · filed 2024-11-06 |
| 2024-03-31 | $33.92M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $0.00 10-Q · filed 2024-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |